Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · ABBOTINDIA

ABBOTT (I)

HealthcarePharmaceuticals & Biotechnology₹54166 cr market cap
₹25695.00 ▲ +0.88% today As of 19 Nov 2026
52-week low ₹25030.0052-week high ₹30205.00

-15.7% from the 52-week high · +1.8% above the low

Abbott India Ltd. engages in the development, manufacture, and sale of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 3,700 full-time employees. The firm has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. The company provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolics, multi-specialty, vaccines and consumer health, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremalax (constipation), Pankreoflat (indigestion) and Duvadilan (preterm labor), among others. The company offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure and Glucerna, among others.

The short version. Promoter holding was 74.99% in Jun 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

ABBOTT (I) trades 15.7% below its 52-week high and 1.8% above its 52-week low.

Change over period: —

1M-1.7%
3M-3.5%
6M-7.2%
1Y-14.1%

4 · The owners

Who holds it, and are they adding?

Promoter holding74.99%

Unchanged over 8 quarters.

Foreign institutions0.38%

Up 0.22 pts over 8 quarters.

Domestic institutions8.78%

Down 0.21 pts over 8 quarters.

Mutual fund schemes169

+36 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Change
Promoter74.9974.9974.9974.9974.9974.9974.9974.990.0
FII0.160.160.160.160.160.180.260.38+0.22
DII8.999.018.929.199.119.08.938.78-0.21
Public15.8515.8415.9315.6615.7515.8315.8115.850.0

Mutual fund holdings · Oct 2026

169 schemes hold this stock

133 the month before.

  • TATA INDIA PHARMA & HEALTHCARE FUND5.66% of NAV
  • Bank of India Mid Cap Fund4.72% of NAV
  • Taurus Mid Cap Fund4.17% of NAV
  • UTI BSE Low Volatility Index Fund3.45% of NAV
  • Motilal Oswal BSE low Volatility Index Fund3.45% of NAV
  • Motilal Oswal BSE Low Volatility ETF3.45% of NAV
  • PGIM INDIA HEALTHCARE FUND3.22% of NAV
  • NJ ELSS Tax Saver Fund3.22% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for ABBOTT (I) are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about ABBOTT (I)

What is the ABBOTT (I) share price?

ABBOTT (I) (ABBOTINDIA) last closed at ₹25,695.00, up 0.88% on the day. Its 52-week range is ₹25,030.00 to ₹30,205.00.

What is the market cap of ABBOTT (I)?

ABBOTT (I) has a market capitalisation of about ₹54,166 crore. Its price-to-earnings ratio is 32.8.

How are ABBOTT (I)'s latest results?

Promoter holding was 74.99% in Jun 2026, up 0.00 points over 8 quarters.

Who owns ABBOTT (I)?

As of Jun 2026, shareholding was: Promoter 74.99%, FII 0.38%, DII 8.78%, Public 15.85%.

How many mutual funds hold ABBOTT (I)?

169 mutual fund schemes held ABBOTT (I) in October 2026. That compares with 133 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 25 Jul 2025 · Final Dividend - Rs. 475
  • 19 Jul 2024 · Final Dividend - Rs. 410
  • 21 Jul 2023 · Final Dividend - Rs. 180
  • 21 Jul 2023 · Special Dividend - Rs. 145
  • 02 Aug 2022 · Special Dividend - Rs. 130
  • 02 Aug 2022 · Final Dividend - Rs. 145

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.